Manohar Kuppusami - Sartorius Aktiengesellscha Head India

All Insiders . USA . 
Stock . Sartorius Aktiengesellschaft . Stakeholders . Insider . Manohar Kuppusami
SARTF Stock  USD 182.98  9.77  5.07%   

Insider

Manohar Kuppusami is Head India of Sartorius Aktiengesellschaft
Phone49 551 308 0
Webhttps://www.sartorius.com

Sartorius Aktiengesellscha Management Efficiency

The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3386 %, meaning that it generated $0.3386 on every $100 dollars invested by stockholders. Sartorius Aktiengesellscha's management efficiency ratios could be used to measure how well Sartorius Aktiengesellscha manages its routine affairs as well as how well it operates its assets and liabilities.
Sartorius Aktiengesellschaft has accumulated 1.65 B in total debt with debt to equity ratio (D/E) of 1.03, which is about average as compared to similar companies. Sartorius Aktiengesellscha has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Sartorius Aktiengesellscha until it has trouble settling it off, either with new capital or with free cash flow. So, Sartorius Aktiengesellscha's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sartorius Aktiengesellscha sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sartorius to invest in growth at high rates of return. When we think about Sartorius Aktiengesellscha's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Kimberly MacKayWest Pharmaceutical Services
58
Rachel GoodrichRepligen
N/A
Amy WakehamResMed Inc
N/A
CPA ParraMerit Medical Systems
46
Stephen TingleyRepligen
N/A
Sondra NewmanRepligen
N/A
Joanne EgaminoSTAAR Surgical
N/A
James BylundRepligen
61
Steven MDCarl Zeiss Meditec
N/A
Craig HarrisonRepligen
N/A
AM AMResMed Inc
80
Patrick WilliamsSTAAR Surgical
51
Markus WeberCarl Zeiss Meditec
N/A
Joseph PierceMerit Medical Systems
N/A
Mike WangCarl Zeiss Meditec
N/A
Molly JosephWest Pharmaceutical Services
46
Brian BonnellICU Medical
50
Andrew ChangCarl Zeiss Meditec
N/A
Robert SeguraWest Pharmaceutical Services
N/A
Constance BienfaitResMed Inc
N/A
Rajwant SodhiResMed Inc
46
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company was founded in 1870 and is headquartered in Gttingen, Germany. Sartorius operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 13832 people. Sartorius Aktiengesellschaft [SARTF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Return On Equity0.34
Return On Asset0.11

Sartorius Aktiengesellscha Leadership Team

Elected by the shareholders, the Sartorius Aktiengesellscha's board of directors comprises two types of representatives: Sartorius Aktiengesellscha inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sartorius. The board's role is to monitor Sartorius Aktiengesellscha's management team and ensure that shareholders' interests are well served. Sartorius Aktiengesellscha's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sartorius Aktiengesellscha's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rene Faber, Member of the Executive Board, Head of the Bioprocess Solutions Division
Petra Kirchhoff, Member of the Supervisory Board, Vice President of Corporate Communications & Investor Relations
Rashid Maqbool, Head USA
Manfred Werner, Sr Auditing
John MacKay, Member of the Executive Board, Head of the Lab Products & Services Division
Patricia Spannagel, Head Goettingen
Mei Wang, Head China
Joachim Kreuzburg, Chairman of the Executive Board, CEO, Executive for Labor Relations
Rainer Lehmann, CFO, Member of the Executive Board
Manohar Kuppusami, Head India

Sartorius Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sartorius Aktiengesellscha a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.34
Return On Asset0.11
Profit Margin0.13 %
Operating Margin0.27 %
Current Valuation27.76 B
Shares Outstanding34.23 M
Shares Owned By Insiders84.78 %
Shares Owned By Institutions3.73 %
Price To Earning58.19 X
Price To Book11.12 X

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Sartorius Pink Sheet

Sartorius Aktiengesellscha financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Aktiengesellscha security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY